Alzamend Neuro, Inc. (ALZN): Price and Financial Metrics


Alzamend Neuro, Inc. (ALZN): $0.66

0.00 (0.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALZN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ALZN Stock Price Chart Interactive Chart >

Price chart for ALZN

ALZN Price/Volume Stats

Current price $0.66 52-week high $1.60
Prev. close $0.66 52-week low $0.49
Day low $0.65 Volume 199,994
Day high $0.70 Avg. volume 317,440
50-day MA $0.83 Dividend yield N/A
200-day MA $0.97 Market Cap 64.00M

Alzamend Neuro, Inc. (ALZN) Company Bio


Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.


ALZN Latest News Stream


Event/Time News Detail
Loading, please wait...

ALZN Latest Social Stream


Loading social stream, please wait...

View Full ALZN Social Stream

Latest ALZN News From Around the Web

Below are the latest news stories about ALZAMEND NEURO INC that investors may wish to consider to help them evaluate ALZN as an investment opportunity.

Alzamend Neuro Inc. (NASDAQ:ALZN) Currently -249.15 Percent Off Its 52-Week High, But Its Upside Possibilities Might Surprise You

In last trading session, Alzamend Neuro Inc. (NASDAQ:ALZN) saw 1.06 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.59 trading at $0.0 or 0.46% at ring of the bell on the day assigns it a market valuation of $54.67M. That closing price of ALZN’s stock is … Alzamend Neuro Inc. (NASDAQ:ALZN) Currently -249.15 Percent Off Its 52-Week High, But Its Upside Possibilities Might Surprise You Read More »

Marketing Sentinel | January 7, 2023

Alzamend Neuro Partners With Biorasi to Conduct a First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase I/IIA Clinical Trial

ATLANTA--(BUSINESS WIRE)---- $ABBV #AD--Alzamend Neuro Partners With Biorasi to Conduct First-in-Human, Randomized, Double-Blind Placebo-Controlled Parallel Group Phase I/IIA Clinical Trial

Business Wire | January 4, 2023

Alzamend Neuro Partners With the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial to Treat Mild to Moderate Dementia of the Alzheimer’s Type

ATLANTA, December 28, 2022--Alzamend Neuro Partners with Miller School of Medicine at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial for AD

Yahoo | December 28, 2022

EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

Alzamend Neuro Inc (NASDAQ: ALZN) has partnered with the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for its Phase 1/2A trial of ALZN002. ALZN002 is an "active" immunotherapy product consisting of autologous dendritic cells (DCs), activated white blood cells taken from each patient that are engineered outside the body to attack Alzheimer's-related amyloid-beta proteins. "We strongly believe that the ALZN002 patient-specific immunotherapeutic vaccin

Yahoo | December 28, 2022

What Can Alzamend Neuro Inc. (NASDAQ: ALZN) Expect In 2022?

Alzamend Neuro Inc. (NASDAQ:ALZN) price on Friday, December 23, fall -2.99% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.65. A look at the stock’s price movement, the close in the last trading session was $0.67, moving within a range at $0.6309 and $0.6935. Turning to its … What Can Alzamend Neuro Inc. (NASDAQ: ALZN) Expect In 2022? Read More »

Stocks Register | December 24, 2022

Read More 'ALZN' Stories Here

ALZN Price Returns

1-mo 16.83%
3-mo -40.00%
6-mo -34.65%
1-year -56.86%
3-year N/A
5-year N/A
YTD 16.83%
2022 -70.27%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6972 seconds.